Targeting oncogenic KRAS with molecular brush-conjugated antisense oligonucleotides. Wang D, Wang Q, Wang Y, Chen P, et al. Proc Natl Acad Sci U S A 2022;119:e2113180119.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang D, Wang Q, Wang Y, Chen P, et al. Targeting oncogenic KRAS with molecular brush-conjugated antisense oligonucleotides. Proc Natl Acad Sci U S A 2022;119:e2113180119.
PMID: 35858356